近日，国家传染病医学中心主任、复旦大学附属华山医院感染科主任张文宏就国内尼帕病毒（Nipah virus）的检测能力作出回应。他表示，中国目前已具备对尼帕病毒的快速检测与识别能力，相关实验室已纳入国家病原微生物监测网络，并可在短时间内完成病毒基因测序和确诊。张文宏强调，尽管尼帕病毒尚未在国内出现本土病例，但鉴于其高致死率（可达40%–75%）及潜在的人传人风险，我国始终将其列为高度关注的新发传染病之一。他指出，通过加强口岸检疫、完善早期预警机制以及提升基层医疗机构的识别能力，可有效防范输入性疫情。此外，张文宏还呼吁公众不必恐慌，应科学看待新发传染病风险，同时支持科研机构加快相关疫苗和治疗药物的研发。总体而言，我国在应对包括尼帕病毒在内的新发突发传染病方面已建立起较为完善的防控体系，具备快速响应和处置能力。
Recently, Dr. Zhang Wenhong, Director of the National Center for Infectious Diseases and Head of the Department of Infectious Diseases at Huashan Hospital affiliated with Fudan University, addressed China’s capacity to detect the Nipah virus. He stated that China currently possesses the capability for rapid detection and identification of the Nipah virus, with relevant laboratories integrated into the national pathogen surveillance network, enabling swift viral genome sequencing and confirmation. Dr. Zhang emphasized that although no indigenous cases of Nipah virus have been reported in China, the country continues to classify it as a high-priority emerging infectious disease due to its high fatality rate (ranging from 40% to 75%) and potential for human-to-human transmission. He noted that strengthening border quarantine, improving early warning systems, and enhancing frontline healthcare workers’ diagnostic awareness are key to preventing imported outbreaks. Dr. Zhang also urged the public not to panic but to adopt a science-based perspective on emerging infectious disease risks, while supporting accelerated research into vaccines and therapeutics. Overall, China has established a robust prevention and control system capable of rapid response to emerging pathogens like the Nipah virus.
原创文章，作者：admin，如若转载，请注明出处：https://ktez.cn/22645.html